Investigational In Vitro Diagnostics in Oncology Trials: Streamlined Submission Process for Study Risk Determination Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 10, 2019
April 24, 2020
ff9a397a-14c7-475f-9b86-e658211b0705
Related Documents
Providing Regulatory Submissions in Electronic Format: IND Safety Reports Guidance for Industry
Guidance DocumentApril 1, 2024Center for Drug Evaluation and Research
Expansion Cohorts: Use in First-In-Human Clinical Trials to Expedite Development of Oncology Drugs and Biologics Guidance for Industry: Guidance for Industry
Guidance DocumentMarch 1, 2022Center for Drug Evaluation and Research
Pediatric Study Plans: Content of and Process for Submitting Initial Pediatric Study Plans and Amended Initial Pediatric Study Plans
Guidance DocumentJuly 31, 2020Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox